# GNT Pharma

Organization · id `cardio:org-gnt-pharma` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=GNT+Pharma>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: GNT Pharma
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Safety and Optimal Neuroprotection of neu2000 in Ischemic Stroke With Endovascular reCanalizion (SONIC) (`cardio:ct-nct02831088`)
- Sponsors: Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients (`cardio:ct-nct03651557`)
- Sponsors: Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz (`cardio:ct-nct05041010`)

## Provenance

Content hash: ff73db277e5edb6a7100e182787645f71a0b767e2b5c91ae26798199281e2e07
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
